Expanding access to BRCA1/2 genetic counseling with telephone delivery: A cluster randomized trial

Journal of the National Cancer Institute

Volumn 106, Issue 12, 2014, Pages

  Kinney, Anita Y ^a,b,c,d   Butler, Karin M ^a   Schwartz, Marc D ^e   Mandelblatt, Jeanne S ^e   Boucher, Kenneth M ^c,d   Pappas, Lisa M ^c   Gammon, Amanda ^c   Kohlmann, Wendy ^c   Edwards, Sandra L ^c,d   Stroup, Antoinette M ^c,d,f   Buys, Saundra S ^c,d   Flores, Kristina G ^a   Campo, Rebecca A ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BOOTSTRAPPING; BRCA2 GENE; BREAST CANCER; CANCER GENETICS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST CONTROL; DECISION MAKING; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SAFETY; STATISTICAL MODEL; TELECONSULTATION; TUMOR SUPPRESSOR GENE; URBAN AREA; BREAST TUMOR; ETIOLOGY; GENETICS; MENTAL STRESS; MIDDLE AGED; MUTATION; OVARY TUMOR; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; REGISTER; RISK; RURAL POPULATION; TELEPHONE; UNITED STATES; URBAN POPULATION;

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HUMANS; LINEAR MODELS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; QUALITY OF LIFE; REGISTRIES; RISK; RURAL POPULATION; STRESS, PSYCHOLOGICAL; TELEPHONE; URBAN POPULATION; UTAH;

EID: 84922392618     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju328     Document Type: Article

References (69)

1. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77(11):2318-2324.
2. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997;336(20):1409-1415.
3. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676-689.
4. Frank TS, Critchfield GC. Hereditary risk of women's cancers. Best Pract Res Clin Obstet Gynaecol. 2002;16(5):703-713.
5. Martin AM, Blackwood MA, Antin-Ozerkis D, et al. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol. 2001;19(8):2247-2253.
6. Spitzer E, Abbaszadegan MR, Schmidt F, et al. Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure. Int J Cancer. 2000;85(4):474-481.
7. Kadouri L, Hubert A, Rotenberg Y, et al. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet. 2007;44(7):467-471.
8. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006;296(2):185-192.
9. Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812-822.
10. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91(15):1310-1316.
11. Moyer VA. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;160(4):271-281.
12. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCARelated Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2014;160(4):255-266.
13. Acheson LS, Stange KC, Zyzanski S. Clinical genetics issues encountered by family physicians. Genet Med. 2005;7(7):501-508.
14. Carroll JC, Brown JB, Blaine S, Glendon G, Pugh P, Medved W. Genetic susceptibility to cancer. Family physicians' experience. Can Fam Physician. 2003;49:45-52.
15. Doksum T, Bernhardt BA, Holtzman NA. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med. 2003;5(2):99-105.
16. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299(11):1320-1334.
17. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42(10):749-755.
18. Trivers KF, Baldwin L-M, Miller JW, et al. Reported referral for genetic counseling or BRCA1/2 testing among United States physicians. Cancer. 2011;117(23):5334-5343.
19. Vogel TJ, Stoops K, Bennett RL, Miller M, Swisher EM. A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk. Gynecol Oncol. 2012;125(3):693-698.
20. Genetic/Familial High-Risk Assessment: Breast and Ovarian Version 4.2013. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2013. Available at: http://www.nccn.org/professionals/physician-gls/pdf/genetics-screening.pdf. Accessed August 22, 2013.
21. Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G. Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol. 2012;2012:298745.
22. Trivers KF, Baldwin LM, Miller JW, et al. Reported referral for genetic counseling or BRCA1/2 testing among United States physicians. Cancer. 2011;117(23):5334-5343.
23. Brandt R, Ali Z, Sabel A, McHugh T, Gilman P. Cancer genetics evaluation: barriers to and improvements for referral. Genet Test. 2008;12(1):9-12.
24. D'Agincourt-Canning L. Genetic testing for hereditary cancer: challenges to ethical care in rural and remote communities. HEC Forum. 2004;16(4):222-233.
25. Fineman R, Doyle D. Public health needs assessment for state-based genetic services delivery. In: Khoury MJ, Burke W, Thomson E, eds. Genetics and Public Health in the 21st Century. Oxford, UK: Oxford University Press; 2000.
26. Mackenzie A, Patrick-Miller L, Bradbury AR. Controversies in communication of genetic risk for hereditary breast cancer. Breast J. 2009;15(Suppl 1):S25-S32.
27. Vadaparampil ST, Wideroff L, Breen N, Trapido E. The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2006;15(4):618-623.
28. Wideroff L, Vadaparampil ST, Breen N, Croyle RT, Freedman AN. Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet. 2003;6(3):147-156.
29. Cohen SA, Marvin ML, Riley BD, Vig HS, Rousseau JA, Gustafson SL. Identification of Genetic Counseling Service Delivery Models in Practice: A Report from the NSGC Service Delivery Model Task Force. J Genet Couns. 2013;22(4):411-421.
30. Brink S. Telehealth: The Ultimate in Convenience Care. U.S. News & World Report. 2013.
31. Hilgart JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med. 2012;14(9):765-776.
32. Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol. 2014;32(7):611-612.
33. Bradbury AR, Patrick-Miller L, Fetzer D, et al. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. Clin Genet. 2011;79(2):125-131.
34. Schwartz MD, Valdimarsdottir HB, Peshkin BN, et al. Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer. J Clin Oncol. 2014: In press.
35. Risk Education and Assessment for Cancer Heredity. Available at: http://clinicaltrials.gov/show/NCT01346761. Accessed October 2, 2014.
36. Hurdle JF, Haroldsen SC, Hammer A, et al. Identifying clinical/translational research cohorts: ascertainment via querying an integrated multisource database. J Am Med Inform Assoc. 2013;20(1):164-171.
37. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604.
38. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.
39. Peshkin BN, Demarco TA, Graves KD, et al. Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial. Genet Test. 2008;12(1):37-52.
40. Trepanier A, Ahrens M, McKinnon W, et al. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns. 2004;13(2):83-114.
41. Dillman D, Smyth J, Christian L. Internet, Mail, and Mixed-Mode Surveys: The Tailored Design Method. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc; 2009.
42. University of Washington Rural Health Research Center: Rural-urban communting area codes (version 2.0). 2006. Available at: http://depts. washington.edu/uwruca/. Accessed October 2, 2014.
43. Derogatis LR. BSI 18 Brief Symptom Inventory 18: Administration, Scoring, and Procedures Manual. Minneapolis, MN: NCS Pearson, Inc.; 2000.
44. Horowitz MJ, Wilner N, Alvarez W. Impact of events scale: A measure of subjective stress. Psychosomatic Medicine. 1979;41(3):209-218.
45. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25-30.
46. O'Connor AM. User Manual - Decisional Conflict Scale 1993 [updated 2010]. Available at: http://decisionaid.ohri.ca/docs/develop/User-Manuals/UM-Decisional-Conflict.pdf. Accessed October 2, 2014.
47. O'Connor AM. User Manual - Decisional Regret Scale 1996 [updated 2003]. Available at: http://decisionaid.ohri.ca/docs/develop/User-Manuals/UM-Regret-Scale.pdf. Accessed October 2, 2014.
48. Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD. Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. Am J Med Genet A. 2005;134A(1):66-73.
49. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
50. Ware JE, Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000;25(24):3130-3139.
51. Street RL Jr. Physicians' communication and parents' evaluations of pediatric consultations. Med Care. 1991;29(11):1146-1152.
52. Eysenck MW, Calvo MG. Anxiety and performance - The processing efficiency theory. Cognition & Emotion. 1992;6(6):409-434.
53. Wakefield CE, Meiser B, Homewood J, et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat. 2008;107(2):289-301.
54. Wakefield CE, Meiser B, Homewood J, Ward R, O'Donnell S, Kirk J. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer. 2008;113(5):956-965.
55. Zabora J, Brintzenhofe Szoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics. 2001;42(3):241-246.
56. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in healthrelated quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.
57. Efron B, Tibshirani R. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC; 1993.
58. Su Y, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R:Opening windows into the black box. J Stat Software. 2011;45(2):1-31.
59. Elashoff JD. nQuery Adviro Version 7.0 User's Guide. Cork: Statistical Solutions Ltd.; 2007.
60. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London, United Kingdom: Arnold; 2000.
61. Prucka SK, McIlvried DE, Korf BR. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example. Med Princ Pract. 2008;17(3):173-189.
62. Cameron LD, Marteau TM, Brown PM, Klein WM, Sherman KA. Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence. J Behav Med. 2012;35(3):286-298.
63. Pollock A. 2 Competitors Sued by Genetics Company for Patent Infringement. The New York Times. July 10, 2013; Business Day: B3.
64. Kinney AY, Simonsen SE, Baty BJ, et al. Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet A. 2006;140(8):813-826.
65. Sie AS, van Zelst-Stams WA, Spruijt L, et al. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling. Fam Cancer. Sep 26 2014;13(2):143-151.
66. Genetic Counseling by Phone. Aetna provides telephone genetic counseling. Available at: http://www.aetna.com/individuals-families/membertools-forms/phone-genetic-counseling.html. Accessed December 3, 2013.
67. Informed Medical Decisions II. InformedDNA and Cigna Collaborate in First National Genetic Testing Program to Require Independent Counseling. 2013. Available at: http://www.prnewswire.com/newsreleases/informeddna-and-cigna-collaborate-in-first-national-genetictesting-program-to-require-independent-counseling-216575131.html. Accessed December 3, 2013.
68. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293(14):1729-1736.
69. Pal T, Stowe C, Cole A, Lee JH, Zhao X, Vadaparampil S. Evaluation of phone-based genetic counselling in African American women using culturally tailored visual aids. Clin Genet. 2010;78(2):124-131.